The Valley Desk

ArticleJournal of medical economicsPublished

Costs per responder for patients with relapsed or refractory multiple myeloma treated with Talquetamab compared with usual care

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Journal of medical economics
Published
Subject terms
Humans; Multiple Myeloma; Antineoplastic Agents; Antibodies, Bispecific; Drug Administration Schedule; Models, Econometric; Aged; Middle Aged; Cost-Benefit Analysis; United States; Female; Male
PubMed ID
41483183
Added to directory
Source checked

Report a correction or request removal